Available by Prescription Only
HCPCS code C9279
CALDOLOR should be used with caution in patients with congestive heart failure, kidney impairment, at risk of blood clots, and in those who have a history of ulcers or gastrointestinal bleeding. When used in such patients, attention to using the lowest effective dose for the shortest time period is important to reduce the risk of serious adverse events. Ibuprofen has been associated with high blood pressure, serious skin reactions, and serious allergic reactions.
The most common adverse events reported in the controlled clinical trials were nausea, flatulence, vomiting, and headache.
CALDOLOR is indicated in adults for the management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, and reduction of fever.
HCPS code J1741 (Please refer to your coding department for complete billing information.)
*Compared to placebo plus morphine. Results of a multi-center, randomized, double-blind, placebo-controlled trial of patients undergoing total knee or hip replacement, reconstruction, or arthroplasty (N=185). Patients received 800 mg Caldolor or placebo preemptively and every 6 hours after surgery. All patients received intra-operative fentanyl; no other analgesia was given during surgery. Pain was assessed in the immediate post-operative period.
Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen
(IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Medicine. 2010;11:1284-1293.
Prescribing Information for Caldolor. Cumberland Pharmaceuticals Inc. Nashville, TN.